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Let-7 microRNACoﬁlin-1, a non-muscle isoform of actin regulatory protein that belongs to the actin-depolymerizing factor
(ADF)/coﬁlin family is known to affect cancer development. Previously, we found that over-expression of
coﬁlin-1 suppressed the growth and invasion of human non-small cell lung cancer (NSCLC) cells in vitro. In
this study, we further investigated whether over-expression of coﬁlin-1 can suppress tumor growth in vivo,
and performed a microRNA array analysis to better understand whether speciﬁc microRNA would be involved
in this event. The results showed that over-expression of coﬁlin-1 suppressed NSCLC tumor growth using the
xenograft tumor model with the non-invasive reporter gene imaging modalities. Additionally, cell motility and
invasion were signiﬁcantly suppressed by over-expressed coﬁlin-1, and down-regulation of matrix metallopro-
teinase (MMPs) -1 and -3 was concomitantly detected. According to the microRNA array analysis, the let-7
family, particularly let-7b and let-7e, were apparently up-regulated among 248 microRNAs that were affected
after over-expression of coﬁlin-1 up to 7 days. Knockdown of let-7b or let-7e using chemical locked nucleic
acid (LNA) could recover the growth rate and the invasion of coﬁlin-1 over-expressing cells. Next, the expression
of c-myc, LIN28 and Twist-1 proteins known to regulate let-7 were analyzed in coﬁlin-1 over-expressing cells,
and Twist-1 was signiﬁcantly suppressed under this condition. Up-regulation of let-7 microRNA by over-
expressed coﬁlin-1 could be eliminated by co-transfected Twist-1 cDNA. Taken together, current data suggest
that let-7 microRNA would be involved in over-expression of coﬁlin-1 mediated tumor suppression in vitro
and in vivo.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cancer development involves uncontrolled cell growth followed by
increased motility and invasion for distant metastasis [1]. Targeting on
both cancer growth and metastasis is one of the strategies for cancer
treatment, such as the adjuvant radiotherapy and chemotherapy.
Because adjuvant radio-chemotherapy usually leads to resistance, it is
of interest to investigate whether concomitant suppression of cancerical Imaging and Radiological
. 2, Linong St., Beitou District,
28201095.growth and metastasis can be raised by certain biomolecules for cancer
control.
Actin cytoskeleton has long been regarded a therapeutic target
because it plays a role in cellular transformation through accelerated
cell proliferation and migration [2,3]. However, the anti-actin agents
isolated from fungi or sea sponges possess universal toxic problems so
that the clinical application is limited [4]. Because actin cytoskeletal or-
ganization is dependent on various actin regulatory proteins (ARPs),
targeting on ARPs may be applicable for inﬂuence actin organization
and cancer development. Although ARP is believed to regulate actin
dynamics for cell division and migration, little is known whether ARP
affects speciﬁc intracellular signaling pathways for malignancy.
Coﬁlin-1 is a ~19 kD, nonmuscle isoform of actin regulatory protein
that belongs to the actin-depolymerizing factor (ADF)/coﬁlin family [5].
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severing the actin ﬁlaments or depolymerizing the ADP bound actin at
the pointed end of the actin ﬁlaments. Coﬁlin-1 is essential for cell
cycle progression, migration, intravasation and invasion of cancer cells
[6,7]. Interestingly, Yap et al. found a biphasic effect between the coﬁlin
level and locomotory rate because over-expression of coﬁlin in
transfected clones up to 4.5 times that of wild-type cells will increase
the locomotory rate of glioblastoma tumor cells, but clones producing
over this amount displayed reduced motile speed [8]. Consistent with
this ﬁnding, we have found that the cell invasion was inhibited by
coﬁlin-1 over-expression of up to 15 folds in H1299 cells [9]. The cell
growth and cell cycle progression were also suppressed by over-
expressed coﬁlin-1 within a dose- and time-dependent manner.[6].
However, the underlying mechanisms of coﬁlin-1 over-expression
caused suppression of growth rate and invasion remain to be addressed.
MicroRNA is a small non-coding RNA with approximately 22 nucle-
otides and participates in diverse biological functions, including differ-
entiation, development, cell cycle, metabolism and apoptosis [10].
Additionally, accumulated literatures have indicated that microRNA is
important for cancer progression [11–13]. Although different types of
microRNA can suppress downstream oncogenes or tumor suppressor
genes, the total amount of microRNA is decreased in cancers compared
to normal tissues [14]. This phenomenon suggests that most of
microRNAs play roles in suppressing tumor progression. For instance,
hsa-let-7 (let-7) microRNA family and hsa-miR-29 (miR-29) family
are down-regulated in lung cancer and breast cancer, and are regarded
tumor suppressors by inducing apoptosis [15–17]. Other microRNA
families such as hsa-miR-34, hsa-miR-200, hsa-miR-185, hsa-miR-107
and hsa-miR-335 are reported to exhibit tumor suppression capacity
by cooperatingwith p53, inhibition of epithelial–mesenchymal transition
and angiogenesis, cell cycle arrest, or inhibition of tumor re-initiation
[18–23]. Therefore, restoration ormaintenance of endogenousmicroRNA
with tumor suppressor ability would be an important strategy for the
design of cancer treatment strategy.
Destabilization of actin cytoskeleton by coﬁlin-1 or actin inhibitors
has been reported to suppress the growth and invasion of a cancer cell
[6,24,25]. MicroRNA has also been reported to regulate the actin cyto-
skeleton to modulate tumor growth, mobility, invasion and metastasis
[26–28].Whether coﬁlin expression caused tumor response is associated
with microRNA regulation is of interest to investigate. In this study, we
ﬁrst examined the effects of over-expressed coﬁlin-1 on tumor growth
using a xenograft tumor model. The cell motility was also compared be-
fore and after over-expression of coﬁlin-1. Subsequently, a survey of
microRNA proﬁles after over-expression of coﬁlin-1 was performed. It
revealed that let-7 microRNA was apparently up-regulated by over-
expressed coﬁlin-1. Interestingly, over-expression of coﬁlin-1 caused
suppression of growth rate and invasion could be compromised by si-
lencing let-7. Additionally, Twist-1 transcription factor that can regulate
let-7 expression was found to mediate the signaling between coﬁlin-1
and let-7. The potent crosstalk among these molecules was discussed.
2. Materials and methods
2.1. Cell culture
Human non-small cell lung adenocarcinoma H1299 cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS),
2 mM L-glutamate, 50 U/ml penicillin and 50 μg/ml streptomycin
(Sigma-Aldrich Co., St. Louis, MO, USA). H1299/tet-on-coﬁlin cell line
was maintained in the medium containing 100 μg/ml hygromycin B
(Invitrogen, Carlsbad, CA, USA), and H1299/tet-on-coﬁlin /EGFP-tk cell
line was maintained in medium containing 100 μg/ml hygromycin B
and 1 μg/ml puromycin (Sigma-Aldrich Co., St. Louis, MO, USA). The
pH of DMEMwas adjusted to 7.0–7.2 using hydrogen chloride because
the antibiotics could change the pH of medium. Cells were maintainedin a 37 °C, humidiﬁed incubator (5% CO2 and 95% air), and routinely
passaged every two days.
2.2. Soft agar colony formation assay
This assay is performed according to previous reportswithmodiﬁca-
tions [29]. Cells (1 × 104) with or without doxycycline treatment were
suspended in 2× DMEM with 20% FBS and mixed with 0.66% soft agar
(Sigma-Aldrich Co., St. Louis, MO, USA) at equal volumes. The mixture
was then seeded into 6-well plates and incubated under 4 °C for 15–
20 min, and then maintained in a humidiﬁed incubator (5% CO2 and
95% air) at 37 °C. During incubation, 0.5 ml of 2× medium was added
to wells every 7 days. After 14 days of incubation, the 6-well plates
were collected, stained with crystal violet for 10 min, rinsed and sub-
jected to microscopic examination for counting colony number (each
colony should be ≥50 cells).
2.3. Plasmids and transfection
H1299/tet-on-coﬁlin stable cell line harbors a tet-on inducible gene
expressive construct that can over-express human coﬁlin-1 by adding
doxycycline as described previously [30]. A bidirectional tet-on induc-
ible gene expressive plasmid named pBI-EGFP-tk-puro was constructed
from pBI-EGFP plasmid (BD Biosciences Clontech Inc., Worcester, MA,
USA) digested using PvuII and NheI restriction enzymes. The herpes
simplex virus type 1-thymidine kinase (HSV1-tk) cDNA was digested
from pORF-HSV1-tk plasmid (a kind gift from Dr. Jeng-Jong Hwang,
National Yang-Ming University) using the same enzymes and cloned
into pBI-EGFP plasmid to obtain the pBI-EGFP-tk plasmid. The puromy-
cin resistant cassette was obtained from RNAi-Ready pSIREN-RetroQ
plasmid (BD Biosciences Clontech Inc., Worcester, MA, USA) and
subcloned into pBI-EGFP-tk plasmid through Klenow enzyme ﬁlled-in
blunt ligation. The resultant pBI-EGFP-tk-puro plasmid was then
transfected into H1299/tet-on-coﬁlin cells to produce H1299/tet-on-
coﬁlin /EGFP-tk stable cells using the jetPEI transfection reagent
(Polyplus-transfection, SA, Illkirch, France). Cells were trypsinized and
split after 24 h of transfection and then selected using puromycin
(2 μg/ml). The survival clones were pooled after one week of selection,
and were validated by functional analysis of EGFP and HSV1-tk expres-
sion (see results).
2.4. Transfection of miRNA inhibitors and luciferase reporter gene assay
For miRNA inhibition, 30 nM chemically modiﬁed locked nucleic
acid (LNATM) (Exiqon, Los Angeles, CA, USA) speciﬁcally targeting
on let-7b (5′-ACCACACAACCTACTACCTC-3′) or let-7e (5′-ACTATA
CAACCTCCTACCTC-3′) was transfected into cells using JetPEI trans-
fection reagent as described above. To determine the inhibitory
effect of let-7 miRNA, a 260 bp 3′-untranslated region (3′-UTR) of
human transformation growth factor beta receptor 1 (TGFBR1)
mRNA encompassing a second seed sequence of let-7 binding site
[31] was ampliﬁed using polymerase chain reaction (PCR) and
cloned into pMIR-REPORTTM-Luciferase plasmid to generate pMIR-
TGFBR1-reporter construct through SpeI and HindIII restriction
enzymes. The primer set for amplifying this 3′UTR fragment was
5′-ACTAGTCTGAATATCATGAACCATG-3′ and 5′-ATACAGTACCATTT
GAGTAACTGAGC-3′. For luciferase reporter gene assay, cells from
different treatments were harvested with passive lysis buffer and the
luciferase activity was analyzed using reporter assay buffer (50 mM
glycylglycin, 1 M magnesium sulfate, 10 mg/ml bovine serum albumin,
and 0.5 M EDTA) mixed with 100 mM adenosine 5′-triphosphate
disodium salt (Sigma-Aldrich Co., St. Louis, MO, USA), 1Mdithiothreitol,
50 mM D-luciferin (Promega Co., Madison, WI, USA). The mixture was
immediately measured using a Wallac-1420 VICTOR2 multilabel reader
(PerkinElmer Co., Waltham, MA, USA).
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H1299/tet-on-coﬁlin cells were treated with or without doxycycline
treatment for 48 h and then trypsinized for counting the total cell num-
ber. Subsequently, 1 × 104 cells were resuspended in serum-free DMEM
mixedwithMatrigel (BD biosciences, San Jose, CA, USA) at 3:1 ratio and
were seeded into transwells. For determination of migration ability,
each transwell was put on a well of a 24-well dish which contained
DMEM with 10% FBS. After 2 days of incubation, the Matrigel inside a
transwell was removed with a cotton stub and each transwell was
ﬁxed by 4% paraformaldehyde for 10 min followed by 30 min staining
in hematoxylin, rinsed, visualized and counted under a bright-ﬁeld mi-
croscope. The cell number in each well in serum-free DMEM was used
to normalize transversed cell counts after two days incubation.
2.6. Time lapse microscopy and motility analysis
H1299/tet-on-coﬁlin cells (2 × 104) were seeded in a 35 mm dish
and treated with doxycycline or left untreated for 48 h. Cell motility
was then detected by acquiring continuous images at 5-min intervals
using a humidiﬁed, CO2-equilibrated chamber with a Leica DM-IRBE
combining a cooled CCD camera and the AQUA COSMOS imaging anal-
ysis software (ORCA-ER, C4742-95, Hamamatsu Photonics, Hamamarsu,
Japan). The moving pathways of individual cells were tracked by posi-
tioning cell nuclei using MetaMorph® software (Molecular Devices,
Inc., CA, USA). A new stack ﬁle was established to make a movie by ac-
quiring an image every 5 min over a period of 16 h. The travel distance
of each cell was then calculated by taking the positions of cell centroid
during the tracking period. Fifteen cells of each group were randomly
selected for analysis of movement distance.
2.7. Western blot analysis and antibodies
Cells were lysed in NP-40 lysis buffer (50mM Tris-HCl; 120mMNaCl
and 0.5% NP-40) containing 20 μg/ml phenylmethylsulfonyl ﬂuoride
(PMSF) (Sigma-Aldrich Co., St. Louis, MO, USA). The crude protein lysates
were collected by centrifugation (12,000 ×g) and the protein concentra-
tionwas determined using the Bradford assay (Bio-Rad Laboratories, Her-
cules, CA, USA). Equal amounts of crude protein lysates from different
treatments were run on sodium dodecyl sulfate (SDS)-polyacrylamide
gels. The fractionated proteins were electro-transferred to polyvinylidine
ﬂuoride (PVDF) membrane in transfer buffer (25 mM Trizma-
base;192mMglycine and 20% v/vmethanol) for 120min. Themembrane
was blocked using TBST buffer (0.8% w/v NaCl; 0.02% w/v KCl; 25 mM
Tris-HCl and 0.1% v/v Tween20) containing 4% skimmilk and then incu-
bated with a primary antibody at 4 °C overnight. The membrane was
then rinsed with TBST buffer followed by horseradish peroxidase
(HRP)-conjugated secondary antibody. Protein signals were detected
using ECL™ detection reagents (PerkinElmer Inc., Waltham, MA, USA).
The primary antibodies used in this study included anti-coﬁlin-1
(Genetex Inc., Irvine, CA, USA), anti-ser3-phospho-coﬁlin-1 (Santa Cruz
Biotechnology Inc., Dallas, TX, USA), anti-Twist-1 (Genetex Inc., Irvine,
CA, USA), anti-MMP1 (Genetex Inc., Irvine, CA, USA), anti-MMP3
(Genetex Inc., Irvine, CA, USA), anti-MMP9 (Genetex Inc., Irvine, CA,
USA), anti-GAPDH (Sigma-Aldrich Co., St. Louis, MO, USA), anti-c-myc
(Genetex Inc., Irvine, CA, USA), anti-LIN28 (Genetex Inc., Irvine, CA,
USA), anti-ﬂag (Sigma-Aldrich Co., St. Louis, MO, USA), and anti-HSV1-
tk (Santa Cruz Biotechnology Inc., Dallas, TX, USA) antibodies.
2.8. Cell uptake assay
H1299/tet-on-coﬁlin-EGFP/tk cells (1.5 × 106) were seeded in two
150 mm2 dishes with or without doxycycline. The serum-free medium
containing radioactive probe 131I-FIAU (0.5 μCi/ml)was then used to re-
place culturemedium after 24 h of incubation. Cells were then collected
at different time points using centrifugation (3500 rpm) for 2 min.Supernatant and pellets were separately frozen with dry ice, and the
radioactivities of these two components were counted using a
γ-scintillation counter (Wallac Wizard 1470, Perkin Elmer, Waltham,
MA, USA). The speciﬁc radioactivity was normalized with the weight
of each component. The ﬁnal accumulation of 131I-FIAU in cells was
calculated using the formula:
Radioactivity of cell pellet
.
Net weight of cell pellet
Radioactivity of medium
.
Net weight of medium
:
2.9. Xenograft tumor model
Sixweeks oldmale nonobese diabetic/severe combined immunodeﬁ-
ciency (NOD/SCID) mice were anesthetized by intra-peritoneal injection
of a mixture of ketamine chloride (50 mg/kg) and xylazine (15 mg/kg).
Subsequently, 5 × 106 cells re-suspended in 100 μl medium were
subcutaneously injected in both thighs of those NOD/SCID mice
using 27-gauge insulin syringes. Tumor volumewas caliperlymeasured
and calculated using this formula: length × (width)2 / 2 [32].
2.10. In vivo ﬂuorescent imaging
Tumor-bearing mice were anesthetized using 2% isoﬂurane and the
IVIS-50 system (Caliper Co., Hopkinton, MA, USA) was used for image
acquisition. The level and quantiﬁcation of ﬂuorescence was deter-
mined by circling the region of interests (ROIs) of animal image with
photon signals at tumor inoculating sites. The intensity of ﬂuorescent
signals was expressed as photons per second per centimeter squared
per steradian (p/s/cm2/sr). Imaging was performed weekly to monitor
the development of tumor growth in mice.
2.11. Positron emission tomography (PET) imaging
The radioactive tracers 18F-2′-ﬂuoro-2′deoxy-1β-D-arabiono-
furanosyl-5-ethyl-uracil (18F-FEAU) and 2-deoxy-2-ﬂuoro-D-glucose
(18F-FDG) were exploited for detecting HSV1-tk expression and tumor
viability using PET imaging, respectively. Tumor-bearing mice were
i.v. injection of 18F-FEAU or 18F-FDG (100 μCi per mouse) for 60 min,
and whole body PET imaging was performed with a microPET R4
system (Concorde Microsystems, Knoxville, TN, USA). Mice were
anesthetized using 2% isoﬂurane and images were acquired for
15 min. The level of radioactivity in the tumors (% dose/g) was
determined by the analysis software (ASIPro VM 6.3.3.0) bundled
with PET. The above-mentioned animal studies and experiments were
approved by the Institutional Animal Care and Use Committee
(IACUC) inNational Yang-MingUniversity. The IACUC approval number
is 951201.
2.12. Microarrays analysis for microRNA expression
Total RNA was extracted using the Trizol reagent (Life-Technologies
Co., Carlsbad, CA, USA) and quantiﬁed using the NanoDrop ND-1000
(ThermoFisher Scientiﬁc Inc.,Waltham,MA,USA). RNAqualitywas deter-
mined using agarose gel electrophoresis. Agilent HumanmiRNA V3 array
was used to determine the global expression of microRNA. The data ob-
tained frommicroarray analysis have been deposited to the Gene Expres-
sion Omnibus of National Center for Biotechnology Information (NCBI-
GEO) database (accession no.: GSE63699).
2.13. Quantiﬁcation of microRNA and mRNA
To measure microRNA levels before and after coﬁlin-1 over-
expression, quantitative PCR (qPCR) of targetedmiRNAwas performed.
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Carlsbad, CA, USA). The cDNA products were then mixed in the Fast
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subjected to the StepOnePlus Real-Time PCR System (Life-Technologies
Co., Carlsbad, CA, USA) according to themanufacturer's instructions. The




AACAGC-3′, respectively. The forward primers of qPCR used for let-
7b, let-7e and let-7i were 5′-GCCGCTTGAGGTAGTAGGTTGT-3′, 5′-
GCCGCTTGAGGtAGGAGGTTGT-3′, and 5′-GCCGCTTGAGGTAGTAGT
TTGT-3′, respectively. The universal reverse primer was used for all
three let-7: 5′-CCAGTGCAGGGTCCGAGGT-3′. The vertebrate U6
small nuclear RNA (snRNA) gene was used as an internal control,
which was ampliﬁed using the primer set: 5′-CGCTTCGGCAGCACAT
ATAC-3′ and 5′-TTCACGAATTTGCGTGTCAT-3′. The forward and re-
verse qPCR primers of Twist-1 were 5′-AGCTACGCCTTCTCGGTCT-3′
and 5′-CCTTCTCTGGAAACAATgACATC-3′, respectively. The forward and
reverse qPCR primers of actin were 5′-GGAAATCGTGCGTGACATTAAG-
3′ and 5′-GGCCATCTCTTGCTCGAAGT-3′, respectively. The forward and
reverse qPCR primers of coﬁlin-1 were 5′-CTCCTCTGGCGTTGAAGACT-
3′ and 5′-GTGCCCTCTCCTTTTCGTTT-3′, respectively.
2.14. Immunohistochemistry
The paraformaldehyde-ﬁxed, parafﬁn-embedded xenograft tumor
samples were used for immunohistochemical staining. Samples were
deparafﬁnized using xylene and then sequentially re-hydrated by 90%,
80% and 70% ethanol. Tissue sections (5 μm)were treatedwith an antigen
retrieval solution [10mM sodium citrate buffer (pH 6.0) containing 0.05%
Tween 20] under boilingwater for 25min. These sampleswere then incu-
bated with anti-coﬁlin-1 antibody (Santa Cruz Biotechnology Inc., Dallas,
Texas, USA) at 37 °C for 1.5 h. Tissue sections were washed by cold PBS
3 times and then incubated with secondary anti-goat HRP antibody
(Santa Cruz Biotechnology Inc., Dallas, TX, USA). Finally, tissue sections
were incubated with 3′,3′-diaminobenzidine (Dako Denmark A/S,
Denmark) until a brown color developed and the tissue sections were
further counterstained with hematoxylin. In a negative control, all
steps were followed except the addition of primary antibody.
2.15. Statistical analysis
Three independent experiments were conducted and each data set
represented themean±S.D. Statistical analysis between controls and ex-
perimental groups were determined using the t test, and p b 0.05 was
considered a signiﬁcant difference.
3. Results
3.1. Over-expression of coﬁlin-1 suppresses the tumor formation in the
xenograft tumor model
To investigate whether over-expression of coﬁlin-1 would suppress
tumor formation in vivo, we used H1299 cells harboring the
tetracycline-inducible (tet-on) gene expression system to conditionally
express exogenous coﬁlin-1 using doxycycline [9]. Exogenous coﬁlin-1
could be induced over 7 folds in this stable H1299/tet-on-coﬁlin cell
line compared to untreated cells (Fig. 1A). Consistent with a previous
study, [6] the cell growth rate of coﬁlin-1 over-expressing cells
(+Doxy) was slower than that of normal cells (-Doxy) as determined
by the hemocytometry of up to ﬁve days of cell culture (Supplementary
ﬁg. 1). Prior to implantation of the tumor cells to the NOD/SCID mice,
we used the soft-agar colony formation assay to compare the in vitro tu-
morigenic ability with or without coﬁlin-1 over-expression in H1299cells. The results showed that coﬁlin-1 over-expressing cells failed to
form colonies in soft agar (Fig. 1B). Thereafter, H1299/tet-on-coﬁlin cells
and H1299/tet-on-vector cells were subcutaneously implanted in right
and left thighs of NOD/SCID mice, respectively. These mice were separat-
ed into two groups (N= 3 each) fed with or without doxycycline (2 mg/
ml v/v in 5% sucrose solution) right after cells were implanted. The results
showed that H1299/tet-on-vector cells could form tumors in both condi-
tions, while H1299/tet-on-coﬁlin cells could not form tumors in mice
treated with doxycycline after ﬁve weeks of implantation (Fig. 1C). The
tumor growth rate was also measured using the caliper to compare the
tumor formation by H1299/tet-on-coﬁlin cells and H1299/tet-on-vector
cells with or without doxycycline (Fig. 1D). Notably, the tumor growth
rate of H1299/tet-on-vector cells was somehow accelerated in doxycy-
cline fed group (Fig. 1E). Because high concentration of doxycycline (10
mg/pellet) has been reported to induce cytotoxicity of tumor cells, [33]
the amount of doxycycline used here should not suppress tumor growth.
Whether accelerated tumor growth is caused by the sucrose solution or
lowdose doxycycline remains to be examined. Additionally, it is observed
that the tumor growth rate of H1299/tet-on-coﬁlin cells was slower than
that of vector transfected H1299 cells in the absence of doxycycline. Be-
cause the basal levels of coﬁlin-1 in these two cell lines are similar, [30]
the different tumor growth rates may be due to the effects of clonal vari-
ance after antibiotic selections [34]. We had compared the cell growth of
different single stable clones and the result conformed to this assumption
(Supplementary ﬁg. 2). Although the growth of H1299/tet-on-coﬁlin cells
formed xenograft tumors were suppressed by doxycycline, the tumor
was re-grown when doxycycline was removed from drinking water
for another four weeks (Supplementary ﬁg. 3). These results suggest
that over-expression of coﬁlin-1 can suppress tumor growth in vivo,
but the tumor formation will recover when this stress is removed.
3.2. Use of reporter gene imaging to monitor the growth of xenograft tumor
in response to induced expression of coﬁlin-1
To simultaneouslymonitor the coﬁlin-1 induction and tumor suppres-
sion in vivo,we stably transfected a tet-on pBI-EGFP-tk-puro dual reporter
plasmid into H1299/tet-on-coﬁlin cell to obtain a stable cell line named
H1299/tet-on-coﬁlin-EGFP/tk cells (see Materials and methods). Doxycy-
cline induced EGFP in this novel cell model was visualized using the ﬂuo-
rescent microscopy (Fig. 2A). These cells (5 × 106) were then
subcutaneously implanted to the left thigh of each of the NOD/SCID
mice. After six weeks of implantation, the tumor-bearing mice
(~100 mm3 size) were fed with doxycycline supplemented water, and
compared to those fedwith normalwater. Using in vivo ﬂuorescent imag-
ing, the EGFP signal at tumor lesionwas detected twoweeks after doxycy-
cline, but it gradually decreased and completely diminished after six
weeks of treatment (Fig. 2B). The photon ﬂux was quantiﬁed at each
time point and compared between mice with or without doxycycline
(Fig. 2C). Concomitantly, the radionucleotide based reporter gene imaging
usingHSV1-tkwas performed. Induction of co-expressedHSV1-tk report-
er gene in H1299/tet-on-coﬁlin-EGFP/tk cells was conﬁrmed using West-
ern blot analysis (Supplementary ﬁg. 4A). The activity of co-expressed
HSV1-tk was also detected using cell uptake assay that 131I-FIAU
was used as a radioactive substrate for HSV1-tk (Supplementary
ﬁg. 4B). For PET imaging, tumors formed by H1299/tet-on-coﬁlin-
EGFP/tk cells were detected in tumor-bearing mice after they were
intravenously injected with 18F-FEAU (Supplementary ﬁg. 4C and
D). Moreover, tumor viability was reduced because tumor uptake of
18F-FDG was reduced in doxycycline treated tumor-bearing mice
(Supplementary Fig. 4E–F). Tumor growth of H1299/tet-on-coﬁlin-
EGFP/tk cells was also suppressed in tumor-bearing mice after they
were treated with doxycycline compared to untreated control
(Fig. 2D). Furthermore, the immunohistochemical staining of the tu-
mors biopsies obtained from tumor-bearing mice showed that coﬁlin-
1 was induced in tumor treated with doxycycline compared to untreat-
ed control (Fig. 2E). Taken together, current data suggest that over-
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in vivo.3.3. Over-expression of coﬁlin-1 reduces cell invasion and motility
We have previously shown that over-expression of coﬁlin-1 causes
morphological change accompanied by destabilization of actin cytoskele-
ton [30]. Here the effects of over-expressed coﬁlin-1 on cell mobility was
examined. H1299/tet-on-coﬁlin cells were induced to over-express
coﬁlin-1 for 48 h and then subjected to the time-lapse microscopy to re-
cord the cellular traveled path and distance for 16 h (Supplementary
video 1 and video 2). The results showed that coﬁlin-1 over-expressing
cells traveled a shorter distance and fewer paths than normal cells
(Figs. 3A and B). Consistent with previous ﬁnding, [9,30] the in vitro
invasion assay showed that over-expression of coﬁlin-1 prohibited cellFig. 1. Effects of coﬁlin-1 over-expression on xenograft tumor. (A) Induction of exogenous co
H1299/tet-on-coﬁlin cells in three-dimensional soft agar before and after induction of coﬁlin-1
cells and vector transfectedH1299 cells to right thighs and left thighs of NOD/SCIDmice (N=6)
(2mg/ml), and others were fedwith normalwater. For each photo, arrows at left and right repr
doxycycline, respectively. (D)Comparison of growth curves of H1299/tet-on-vector tumor inNO
cells. (E) Comparison of growth curves of H1299/tet-on-coﬁlin tumor in NOD/SCID mice treateinvasive ability using theMatrigel coated transwells (Figs. 3C andD). Sub-
sequently, we analyzed whether the expressions of matrix metallopro-
teinase (MMP), including MMP-1, MMP3 and MMP-9 were affected by
over-expressed coﬁlin-1. The Western blot data showed that these
MMPs were differently suppressed after over-expression of coﬁlin-1
(Fig. 3E). Among them,MMP-1 andMMP-3were signiﬁcantly suppressed
by over-expressed coﬁlin-1 (Fig. 3F). Therefore, over-expression of
coﬁlin-1 not only suppresses tumor formation in vivo but also inhibits
cell motility and invasion in vitro.3.4. Over-expression of coﬁlin-1 inﬂuences the expressive proﬁle of
microRNA
The molecular mechanisms of growth and migration inhibition
caused by coﬁlin-1 were largely unknown. Accumulated literaturesﬁlin-1 in H1299/tet-on-coﬁlin cells using doxycycline (1 μg/ml). (B) Sphere formation of
over-expression. (C) The xenograft tumor formed by s.c. implanting H1299/tet-on-coﬁlin
, respectively. Three of thesemicewere fedwith doxycycline supplementeddrinkingwater
esent the tumor formed byH1299/tet-on-vector and H1299/tet-on-coﬁlin with orwithout
D/SCIDmice treatedwith orwithout doxycyclineup to 34days after implantation of tumor
d with or without doxycycline up to 34 days after implantation of tumor cells.
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actin cytoskeleton and suppress the tumorigenesis [35]. Thus, we used
the microarray analysis for microRNA to examine the expression of
approximately 1000 microRNAs. Among them, 248 microRNAs were
differentially affected inH1299/tet-on-coﬁlin cells after theywere treated
with doxycycline for 2 days and 7 days. We focused on several
microRNAs, including hsa-miR29, [16] hsa-miR34a, [36] hsa-miR335,
[37] hsa-miR200 family, [38] hsa-miR185, [39] hsa-miR107 [19] and
hsa-let7 family [40] that have been reported to negatively regulate tu-
morigenesis, and found that let-7b and let-7emicroRNAwere apparently
up-regulated (N2 folds) after over-expression of coﬁlin-1 for 7 days
(Fig. 4A). Actually, expression of all let-7 family members were up-
regulated by over-expressed coﬁlin-1 (Fig. 4B). Over-expression of
coﬁlin-1 affected expressions of let-7b, let-7e, and let-7i were further
conﬁrmed using qPCR analysis, and the results were consistent with mi-
croarray data (Fig. 4C). Therefore, current data suggest that long-term
over-expression of coﬁlin-1 would inﬂuence microRNA let-7b and
let-7e of H1299/tet-on-coﬁlin cells.3.5. Inhibition of let-7b and let-7e expression compromises the coﬁlin-1
over-expression suppressed cell growth and invasion
To investigate whether let-7b and let-7e are involved in mediating
coﬁlin-1 caused tumor suppression, commercially available locked
nucleic acids (LNA) targeting on let-7b and let-7e were transfected to
coﬁlin over-expressing cells to examine if the cell growth rate andFig. 2.Use of optical imaging tomonitoring the tumor suppressive kinetics by over-expressed co
cycline (1 μg/ml). (B) Design of in vivo experiments for optical imaging is shown. Doxycycline tr
in tumor-bearingmice (N=6) after 2weeks of doxycycline treatment. (C) Quantiﬁcation of ﬂu
doxycycline up to 6 weeks. *: p b 0.05. (D) Comparison of tumor growth rates of H1299/tet-
(E) Immunohistochemical staining of co-expressed coﬁlin-1 in tumor sections obtained from tinvasion ability would be changed. Because the TGFBR1 mRNA is a di-
rect target of let-7, [31,41] we constructed a pMIR-TGFBR1-luc reporter
plasmid to estimate the inhibitory efﬁciency of LNAs. After transfection
of the reporter plasmid into H1299/tet-on-coﬁlin cells, the luciferase
activity was suppressed after doxycycline, but it was recovered by co-
transfected LNAs targeting on let-7b or let-7e (Fig. 5A). These data
suggest that over-expression of coﬁlin-1 up-regulated let-7 can be sup-
pressed by LNA. We next examined the cell growth rate under these
conditions, and the results were consistent with the data of LNA medi-
ated let-7 inhibition that either LNA could compromise the effects of
over-expressed coﬁlin-1 on suppression of cell growth (Fig. 5B). More-
over, inhibition of both let-7 types by LNAs could recover the invasion
ability that had been inhibited by over-expressed coﬁlin-1 (Fig. 5C). It
appeared that the invasive ability of coﬁlin-1 over-expressing cells
was even higher than that of normal cells after LNA treatment, suggest-
ing that let-7 may inﬂuence cell invasion and growth at different path-
ways. Together, these data demonstrate that let-7 tends to mediate
over-expressed coﬁlin-1 suppressed cell growth and invasion.3.6. Involvement of Twist-1 transcription factor in coﬁlin-1 mediated up-
regulation of let-7
The expression of the let-7 family has been reported to be regulated
by Twist-1, c-myc and LIN28 via differentmechanisms [42,43].We then
analyzed the expression of these proteins after over-expression of
coﬁlin-1. TheWestern blot results showed that Twist-1was signiﬁcantlyﬁlin-1. (A) Visualization of induced EGFP inH1299/tet-on-coﬁlin-EGFP/tk cells using doxy-
eatment inducedmaximumﬂuorescent signals at formed tumors (~100mm3, arrowhead)
orescent signals by selected region of interest (ROI) in tumor-bearingmicewith or without
on-coﬁlin-EGFP/tk cells in tumor-bearing mice with or without doxycycline treatment.
umor-bearing mice with or without doxycycline treatment for 2 weeks.
Fig. 3. Effects of coﬁlin-1 over-expression onmobility and invasion of H1299/tet-on-coﬁlin cells. (A) Visualization and recording of cells movement with or without doxycycline using the
time lapse microscopy. (B) Quantiﬁcation and comparison of distance traveled of cells. a.u.: arbitrary unit. *: p b 0.05. (C) In vitro invasion assay using the Matrigel coated transwells.
(D) Comparison of the ratio of transversed cells between doxycycline treated and untreated groups. *: p b 0.05. (E) Western blot analysis of MMP-1, MMP-3 and MMP-9 levels before
and after induction of coﬁlin-1 over-expression. (F) Densitometric quantiﬁcation of MMPs using Image J software. The result of each band was normalized to GAPDH, and each datum
represented the mean ± S.D. of three independent experiments. *: p b 0.05;**: p b 0.001.
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not affected (Fig. 6A). Quantitative PCR showed that over-expression of
coﬁlin-1 could down-regulate basal level of Twist-1 mRNA, whereas
over-expression of Twist-1 did not signiﬁcantly inﬂuence the basal
level of coﬁlin-1 mRNA (Fig. 6B). Over-expression of Twist-1 was
achieved by transfection of pFLAG-Twist-1 plasmid and the expression
ofﬂag tagged Twist-1was conﬁrmedusing anti-ﬂag and anti-Twist-1 an-
tibodies (Fig. 6C). Furthermore, over-expression of coﬁlin-1 mediated
up-regulation of let-7 could be eliminated by concomitant over-
expression of Twist-1 (Fig. 6D). We also showed that over-expression
of Twist-1 or inhibition of let-7 using LNA increased cellular invasion
(Fig. 6E). These data suggest that coﬁlin-1 induced let-7 expression is as-
sociated with regulation of Twist-1 transcription factor, and this signal-
ing pathway may explain the effects of over-expressed coﬁlin-1 on
inhibition of cell invasion.
4. Discussion
Accumulated evidence have supported that coﬁlin-1 should play a
role in cancer progression [44,45]. Whether coﬁlin-1 over-expressioncan affect cancer progression in a small animal is rarely studied. Here
we used NOD/SCID mice that were subcutaneously implanted with
H1299 cells harboring a tet-on system to demonstrate that doxycycline
induced exogenous coﬁlin-1 could suppress tumor growth compared to
parental H1299 cells. Interestingly, tumorswere re-grown after doxycy-
clinewas removed from thewater (Supplementary ﬁg. 3). Additionally,
in vitro studies showed that over-expressed coﬁlin-1 reduced cellmotility
and invasion, although we did not detect any distant metastasis in the
xenograft tumor model (data not shown). Therefore, coﬁlin-1 over-
expression would suppress the growth of tumor cells in vivo and
in vitro, at least in our experimental model.
On the other hand, siRNA mediated knockdown of coﬁlin-1 in
H1299/tet-on-coﬁlin cells led to cell death but not accelerated cell
growth (Supplementary ﬁg. 5). This is consistent with previous reports
that coﬁlin-1 is essential for cell division and viability [46,47]. Actually,
our previous study has revealed that over-expression of coﬁlin-1 can ar-
rest cell cycle but not promote apoptosis [6]. Therefore, over-expression
and knockdown of coﬁlin-1 would cause cell growth suppression
and death, respectively. These observations further emphasize that
strict regulation of coﬁlin-1 level is important for cell growth under
Fig. 4.Effects of coﬁlin-1 over-expression on the expressive proﬁle ofmicroRNA. (A) Comparing the change of selectedmicroRNAs inH1299/tet-on-coﬁlin cellswith doxycycline treatment
for 2 days and 7 days. The levels of these microRNAs were obtained from the microarray analysis. (B) The fold change of let-7 microRNA family in H1299/tet-on-coﬁlin cells after
doxycycline treatment. Let-7b and let-7e increased over 2 folds at 7 days of doxycycline treatment compared to untreated control. (C) Use of qPCR to conﬁrm the results of microarray
analysis for let-7b, let-7e, and let-7i.
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ence the cell motility aswell as the let-7 expressionwould be of interest
to study using a conditional gene knockdown system.
To track the tumor suppression by coﬁlin-1 over-expression
in vivo, we introduced the reporter gene imaging because this
novel technique has been widely used for noninvasively monitoring
tumor growth and metastasis in small animals [48–50]. We con-
structed a bidirectional tet-on dual reporter plasmid that was
transfected to H1299/tet-on-coﬁlin cells to concomitantly track the
expression of coﬁlin-1 and tumor suppression in tumor-bearing mice
by optical imaging and radionucleotide based imaging. This reporter
gene system was actually designed to report both gene-of-interest
and its effects on tumor progression. Indeed, we could detect the
tumor progression using the optical imaging. The co-induced coﬁlin-1
was further conﬁrmed by IHC analysis of tumor sections. Using this im-
aging approach, we could reduce animal amount to track the effect of
coﬁlin-1 on tumor suppression because the sacriﬁce of animals at each
time point is not required.Whether over-expression of coﬁlin-1 can suppress the motility is
controversial. Yap. et al. have reported that over-expression of
coﬁlin-1 mediated motility of glioblastoma cells is concentration de-
pendent [8]. However, another report shows that over-expression of
serine-3 phosphorylated mutant coﬁlin-1 (S3D) results in an almost
complete inhibition of cell motility in human colon adenocarcinoma
cells [51]. Although wild-type coﬁlin-1 was induced to express in
our cell model, it can be normally phosphorylated on serine-3 [6].
Therefore, modulation of cell motility by over-expressed coﬁlin-1
may not only depend on the protein concentration but also the
phosphorylation status of coﬁlin-1. Although it has not been proven,
different types of cancer cells may also exhibit different motilities in
response to over-expressed coﬁlin-1. The invasive ability of cancer
cells is usually associated with the secretion of MMPs. Here we
found that MMP-1 and MMP-3 were signiﬁcantly down-regulated
by over-expressed coﬁlin-1. Because over 20 types of MMP are known,
whether other MMPs can also be inﬂuenced by over-expressed coﬁlin-1
remains to be examined.
Fig. 5. Inhibition of let-7b and let-7e compromises over-expressed coﬁlin-1 mediated
suppression of cell growth and invasion. (A) Use of pMIR-TGFBR1-luc reporter
plasmid conﬁrms that let-7b or let-7e can be inhibited by LNA in coﬁlin-1 over-expressing
cells. (B) Effects of let-7b and let-7e speciﬁc inhibitors on the growth rate of coﬁlin-1 over-
expressing cells. (C) Effects of let-7b and let-7e speciﬁc inhibitors on the invasive ability of
coﬁlin-1 over-expressing cells *: p b 0.05.
859C.-H. Tsai et al. / Biochimica et Biophysica Acta 1852 (2015) 851–861Because the motility and the invasion of tumor cells were sup-
pressed by coﬁlin-1 over-expression, it is of interest to further investi-
gate the putative molecular mechanisms for this observation. Here we
investigated the microRNA expressive proﬁle after over-expression of
coﬁlin-1 up to 7 days, and showed that the let-7 microRNA family, par-
ticularly let-7b and let-7e were apparently up-regulated compared to
other microRNA. The let-7 microRNA family has been reported to be
down-regulated in various cancer types, and re-introduction of let-7
into cancer cells leads to suppression of the tumorigenesis [52,53].
Here we also showed that inhibition of let-7 using LNAs in coﬁlin-1
over-expressing cells could recover their growth rate and invasiveability (Fig. 5B and C). One of the interesting observations is that use
of either let-7b or let-7e targeted LNA could recover nearly 90% of cell
growth rates in coﬁlin over-expressing cells. It is unclear whether the
effects of let-7b and let-7e on cell growth are independent or additive.
We investigated whether transfection of either LNA would inﬂuence
the expression of both let-7b and let-7e. The results showed that the ex-
pression of both let-7b and let-7e were inhibited by transfection of ei-
ther LNA, suggesting that a potent interaction between let-7 members
may exist (Supplementary ﬁg. 6). Because only three nucleotides are
different between these two LNAs and they have the same seed se-
quence (5′-TACCTC-3′), it is also not excluded that the speciﬁcity of
LNA is insufﬁcient to distinguish the functions of different let-7 mem-
bers on cell growth. Nevertheless, it is believed that let-7b and let-7e
should play a role inmediating the functions of coﬁlin-1 on cell growth.
It has been reported that enforced expression of let-7b can affect
actin dynamics related genes and inhibit cell motility [28]. Therefore,
although coﬁlin-1 can directly bind to actin ﬁlaments and affect actin
dynamics, it seems that over-expressed coﬁlin-1 can also regulate actin
dynamics via up-regulate let-7 microRNA. Because over-expression of
coﬁlin-1 can destabilize actin cytoskeleton, it remains unclear that let-7
is up-regulated before or after destabilization of actin cytoskeleton.
Investigation of let-7 expression using actin inhibitors may answer this
question.
Little is known about the molecular pathway for let-7 regulation,
although c-myc and LIN28 has been reported to be the regulators of
the let-7 family [54,55]. A recent report also showed that the epithelial
mesenchymal transition (EMT) regulator Twist-1 is involved in reg-
ulation of let-7i, a member of the let-7 family [42]. We examined the
expression of these three molecules after over-expression of coﬁlin-1.
Surprisingly, Twist-1 is the only molecule to be affected by over-
expressed coﬁlin-1. Over-expression of Twist-1 could suppress the
up-regulated let-7 induced by over-expressed coﬁlin-1, suggesting
that Twist-1 down-regulation is required for coﬁlin-1 mediated
up-regulation of let-7. Although the levels of c-myc and LIN28 are
not affected by over-expressed coﬁlin-1, their activity or subcellular
distribution may need to be further investigated to conclude their
importance on coﬁlin-1 mediated let-7 expression.
In summary, we used a xenograft tumor model to demonstrate that
forced expression of coﬁlin-1 could suppress the formation of subcuta-
neous tumor formed by human NSCLC cells. Over-expression of
coﬁlin-1 also reduced the invasion and motility of cancer cells in vitro.
We focused on the change of microRNA proﬁles, and found that let-7b
and let-7e microRNAs were apparently up-regulated by long-term
over-expression of coﬁlin-1. Concomitantly, the potent let-7 regulator
Twist-1 transcription factor was down-regulated by over-expressed
coﬁlin-1. Transduction of Twist-1 into coﬁlin-1 over-expressing cells
could inhibit let-7 level that was up-regulated by over-expressed
coﬁlin-1. Therefore, current data suggest that over-expression of
coﬁlin-1 would affect tumor progression through elevation of let-7
microRNA. This may provide a novel signaling pathway between coﬁlin
and let-7 to inﬂuence tumor development.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.01.007.
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